Puromycin

This classification denotes a protein synthesis inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula C22H29N7O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4A6ZS6Q2CL, chemically known as 3123l, dihydrochloride but generally known as puromycin, which bears US NIH Compound Identifier 4984. European Medicines Agency schedules Puromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10161MIG. The term PUROMYCIN is an International Non-Proprietary Name. PUROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule puromycin under HS 29419000 and SITC 54139. As of Q4 2014, PUROMYCIN remains the US FDA Preferred Term for this commodity. Puromycin bears US NLM identifiers UMLS ID C0034145 and NCI Concept Code C787. SMILES: O1C(C(NC(=O)C(N)CC2CCC(OC)CC2)C(O)C1N1C2NCNC(N(C)C)C2NC1)CO.